Cutempa Medcial AG

Cutempa Medical Ltd is a medical device company, developing a platform for the treatment of chronic and acute wounds. First focus is diabetic food ulcer, as this is an urgent global issue with 20 million patients globally. The initial products are based on hydrophilic and hydrophobic silica aerosol, which will be converted into an microparticle powder with large surface area by a specific manufacturing process. The product patents have been submitted for Europe, North America, China. Early interest from Global Wound Players has already been raised - with early offers for an acquisition. Therefore, own commercialization plan will be activated only in case exit discussions will not be successful.